Actio Biosciences
Manufacturing · California, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
11202 El Camino Real Ste 100, San Diego,...Website
www.actiobiosciences.comRevenue
$10.6 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
2
1
1
1
1
1
About Actio Biosciences
Actio Biosciences leverages genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare and common diseases. The company is headquartered in San Diego, California.Explore more
Actio Biosciences Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Actio Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Actio Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Actio Biosciences has new funding data
Congratulate Masked Content for being promoted to Masked Content at Actio Biosciences
Product Launch: Get notified when Actio Biosciences launches new products
Click to see if Actio Biosciences had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check if Actio Biosciences has recently received funding, and reach out quickly before it becomes old news!
Check out if Actio Biosciences is spiking on competitors!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Actio Biosciences recently announced quarterly report
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to Actio Biosciences
Compare insights from companies similar to Actio Biosciences, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Actio Biosciences is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Actio Biosciences is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Actio Biosciences.
Actio Biosciences financials insights
Gather financial insights about Actio Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2023
Series A
$55M
2025
Series B
$66M
Actio Biosciences Tech Stack
A closer look at the technologies used by Actio Biosciences
See more technologies
Most Recent Scoops
Funding
Funding
Event
Product Marketing, Events, Learning & Development, Software, Bioengineering, Pharmaceuticals, Public Health, Field /Outside Sales, Field Marketing, Healthcare Technology, Patient Experience
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Lateral Move
Executive Move
Executive Moves, Lateral Move
Actio Biosciences News & Media
Actio Biosciences to Participate in Evercore Emerging Private Biotech Conference
SAN DIEGO--(BUSINESS WIRE)--Actio Biosciences, a clinical-stage biotechnology company leveraging a novel approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that David Goldstein, Ph.D., co-founder and CEO, will present a company overview as part of the rare disease panel at the Evercore Emerging Private Biotech Conference on Monday, July 14, 2025, at 9:00 a.m. ET in Newport, Rhode Island.Actio Biosciences Raises $66 Million in Series B to Advance Genetics-Driven Therapeutics
Actio Biosciences has secured $66 million in a Series B […]Actio Biosciences Secures $66 Million Series B Financing to Advance Genetics-Driven ...
Actio Biosciences, a clinical-stage biotechnology company leveraging a novel approach to genetics and precision medicine to develop new therapeutics that tar...Actio Biosciences to Participate in Piper Sandler Spring Biopharma Symposium
SAN DIEGO--(BUSINESS WIRE)--Actio Biosciences, a clinical-stage biotechnology company leveraging a novel platform approach to genetics and precision medicine to develop new therapeutics that target shared underlying biology in both rare and common diseases, today announced that management will participate in one-on-one investor meetings at the Piper Sandler Spring Biopharma Symposium on Wednesday, April 16th in Boston. About Actio Biosciences Actio Biosciences is leveraging advances in precisio
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Actio Biosciences
Sign Up For FreeTo access detailed company insights
Actio Biosciences leverages genetics and precision medicine to develop life-changing treatments that target underlying shared biology between rare and common diseases. The company is headquartered in San Diego, California.... Read More
